Genome-wide association studies (GWASs) have identified a number of genetic risk loci associated with systemic sclerosis (SSc) and Crohn’s disease (CD), some of which confer susceptibility to both diseases. In order to identify new risk loci shared between these two immune-mediated disorders, we performed a cross-disease meta-analysis including GWAS data from 5,734 SSc patients, 4,588 CD patients and 14,568 controls of European origin. We identified 4 new loci shared between SSc and CD, IL12RB2, IRF1/SLC22A5, STAT3 and an intergenic locus at 6p21.31. Pleiotropic variants within these loci showed opposite allelic effects in the two analysed diseases and all of them showed a significant effect on gene expression. In addition, an enrichment in the IL-12 family and type I interferon signaling pathways was observed among the set of SSc-CD common genetic risk loci. In conclusion, through the first cross-disease meta-analysis of SSc and CD, we identified genetic variants with pleiotropic effects on two clinically distinct immune-mediated disorders. The fact that all these pleiotropic SNPs have opposite allelic effects in SSc and CD reveals the complexity of the molecular mechanisms by which polymorphisms affect diseases.

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease / D. Gonzalez-Serna, E. Ochoa, E. Lopez-Isac, A. Julia, F. Degenhardt, N. Ortego-Centeno, T.R.D.J. Radstake, A. Franke, S. Marsal, M.D. Mayes, J. Martin, A. Marquez, S. Assassi, X. Zhou, F.K. Tan, F.C. Arnett, J.D. Reveille, O. Gorlova, W.V. Chen, J. Ying, P.K. Gregersen, A.T. Lee, A.E. Voskuyl, J. de Vries-Bouwstra, C. Magro-Checa, J. Broen, B.P.C. Koeleman, C.P. Simeon, V. Fonollosa, A. Guillen, P. Carreira, I. Castellvi, M.A. Gonzalez-Gay, R. Rios, J.L. Callejas-Rubio, J.A. Vargas-Hitos, R. Garcia-Portales, M.T. Camps, A. Fernandez-Nebro, M.F. Gonzalez-Escribano, F.J. Garcia-Hernandez, M.J. Castillo, M.A. Aguirre, I. Gomez-Gracia, L. Rodriguez-Rodriguez, B. Fernandez-Gutierrez, P.G. de la Pena, E. Vicente, J.L. Andreu, M. Fernandezde Castro, F.J. Lopez-Longo, L. Martinez, G. Espinosa, C. Tolosa, A. Pros, M. Rodriguez-Carballeira, F.J. Narvaez, M. Rubio-Rivas, V. Ortiz-Santamaria, A.B. Madronero, B. Diaz, L. Trapiella, A. Sousa, M.V. Egurbide, P. Fanlo-Mateo, L. Saez-Comet, F. Diaz-Gonzalez, V. Hernandez, E. Beltran, J.A. Roman-Ivorra, E. Grau, J.J. Alegre-Sancho, F.J. Blanco-Garcia, N. Oreiro, M. Freire, A. Balsa, A.M. Ortiz, N. Hunzelmann, G. Riemekasten, J.H.W. Distler, T. Witte, P. Airo, L. Beretta, A. Santaniello, C. Bellocchi, C. Lunardi, G. Moroncini, A. Gabrielli. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 10:1(2020), pp. 1862.1-1862.11. [10.1038/s41598-020-58741-w]

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

C. Bellocchi;
2020

Abstract

Genome-wide association studies (GWASs) have identified a number of genetic risk loci associated with systemic sclerosis (SSc) and Crohn’s disease (CD), some of which confer susceptibility to both diseases. In order to identify new risk loci shared between these two immune-mediated disorders, we performed a cross-disease meta-analysis including GWAS data from 5,734 SSc patients, 4,588 CD patients and 14,568 controls of European origin. We identified 4 new loci shared between SSc and CD, IL12RB2, IRF1/SLC22A5, STAT3 and an intergenic locus at 6p21.31. Pleiotropic variants within these loci showed opposite allelic effects in the two analysed diseases and all of them showed a significant effect on gene expression. In addition, an enrichment in the IL-12 family and type I interferon signaling pathways was observed among the set of SSc-CD common genetic risk loci. In conclusion, through the first cross-disease meta-analysis of SSc and CD, we identified genetic variants with pleiotropic effects on two clinically distinct immune-mediated disorders. The fact that all these pleiotropic SNPs have opposite allelic effects in SSc and CD reveals the complexity of the molecular mechanisms by which polymorphisms affect diseases.
Settore MED/09 - Medicina Interna
Settore MED/16 - Reumatologia
2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
41598_2020_Article_58741.pdf

accesso aperto

Descrizione: Articolo
Tipologia: Publisher's version/PDF
Dimensione 2.1 MB
Formato Adobe PDF
2.1 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/957429
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 13
social impact